主动呼吸循环技术联合超声药物透入治疗COPD的随机对照试验方案
本研究为单盲随机对照试验方案,拟纳入75例住院COPD伴痰液过多患者,分三组分别接受主动呼吸循环技术联合超声药物透入、单用主动呼吸循环技术、单用超声药物透入,每日干预1周。主要结局为痰液黏稠度与痰量变化、肺功能及脉搏血氧饱和度,次要结局包括COPD评估测试、呼吸疾病焦虑量表、满意度、配合度及住院时长,采用方差分析比较组间差异,p<0.05为有统计学意义。
要点
- 主动呼吸循环技术联合超声药物透入可能改善COPD患者痰液清除。
- 研究采用单盲三臂设计,每日干预1周,主要结局含痰液黏稠度与肺功能。
- 次要结局涵盖CAT评分、焦虑量表、满意度、配合度及住院时长。
核心结论
- 该方案旨在探索主动呼吸循环技术联合超声药物透入治疗COPD住院患者的效果与安全性。
- 若联合干预有效,可能成为COPD患者更好的治疗选择。
研究设计与样本
- 单盲随机对照试验,纳入75例确诊COPD且痰液过多的住院患者。
- 分三组:联合干预组、单用主动呼吸循环技术组、单用超声药物透入组。
- 干预每日实施,持续1周。
- 采用方差分析比较组间差异,p<0.05(双尾)为有统计学意义。
关键数值与推荐
- 主要结局为痰液黏稠度与痰量变化、肺功能及脉搏血氧饱和度。
- 次要结局包括COPD评估测试量表、呼吸疾病焦虑量表、自满意度、配合度及住院时长。
- 除痰量和额外次要结局外,所有结局在基线及干预1周后评估。
临床怎么用
- 针对住院COPD伴痰液过多患者,可考虑主动呼吸循环技术联合超声药物透入作为气道清除策略。
- 干预周期为每日1次、持续1周,需评估痰液黏稠度、肺功能及血氧饱和度变化。
局限性
- 该文为研究方案,尚未报告实际干预效果与安全性数据。
- 样本量75例,为初步随机对照试验,统计效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease characterized by coughing, the production of excess sputum, and dyspnea. Patients with excessively thick sputum may have frequent attacks or develop more serious disease. The guidelines recommend airway clearance for patients with excessive sputum who are hospitalized with COPD. The active cycle of breathing technique is the most common non-pharmacological airway clearance technique used by physiotherapists. However, the effectiveness of the technique is not always guaranteed. Active cycle of breathing techniques require the initial dilution of the sputum, usually by inhalation drugs, which may have limited effects. Recent studies have found that phonophoresis decreases inflammation, suggesting the potential of the combined usage of active cycle of breathing techniques and phonophoresis. Therefore, the aim of this study is to explore the effectiveness and safety of combining active cycle of breathing technique and phonophoresis in treating COPD patients. METHODS AND ANALYSIS: We propose a single-blind randomized controlled trial using 75 hospitalized patients diagnosed with COPD with excessive sputum production. The patients will be divided into three groups. The intervention group will receive active cycle of breathing techniques combined with phonophoresis. The two comparison groups will be treated with active cycle of breathing techniques and phonophoresis, respectively. The program will be implemented daily for 1 week. The primary outcomes will be changes in sputum viscosity and production, lung function, and pulse oximetry. Secondary outcomes include the assessment of COPD and anxiety, measured by the COPD Assessment Test scale and the Anxiety Inventory for Respiratory Disease, respectively; self-satisfaction; the degree of cooperation; and the length of hospital stay. All outcome measures, with the exception of sputum production and additional secondary outcomes, will be assessed at the commencement of the study and after 1 week's intervention. Analysis of variance will be used to investigate differences between the groups, and a p-value of less than 0.05 (two-tailed) will be considered statistically significant. DISCUSSION: This study introduces a combination of active cycle of breathing techniques and phonophoresis to explore the impact of these interventions on patients hospitalized with COPD. If this combined intervention is shown to be effective, it may prove to be a better treatment for patients with COPD. TRIAL REGISTRATION: The trial was registered prospectively on the Chinese Clinical Trial Registry on 24 December 2019.ClinicalTrials.gov ChiCTR1900028506 . Registered on December 2019.
引用
- Shen MD, Guo LR, Li YW, et al. Role of the active cycle of breathing technique combined with phonophoresis for the treatment of patients with chronic obstructive pulmonary disease (COPD): study protocol for a preliminary randomized controlled trial. Trials. 2021. PMID: 33757568. doi:10.1186/s13063-021-05184-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。